Log In
Print
BCIQ
Print
Print this Print this
 

Orenitram, oral treprostinil (UT-15C)

Also known as: treprostonil diethanolamine

  Manage Alerts
Collapse Summary General Information
Company United Therapeutics Corp.
DescriptionSustained-release oral formulation of treprostinil, a synthetic long-acting stable prostacyclin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation U.S. - Undisclosed Review (Treat pulmonary arterial hypertension (PAH))
Partner Supernus Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$30.0M

$30.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today